##Abrigo, J., Simon, F., Cabrera, D., Vilos, C., & Cabello-Verrugio, C. (2019). Mitochondrial dysfunction in skeletal muscle pathologies. Current Protein and Peptide Science, 20(6), 536-546. ##Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M., Druschel, C., Curt, A., & Fehlings, M. G. (2017). Traumatic spinal cord injury. Nature reviews Disease primers, 3(1), 1-21. ##Alamdari, N., Aversa, Z., Castillero, E., Gurav, A., Petkova, V., Tizio, S., & Hasselgren, P.-O. (2012). Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism. Biochemical and biophysical research communications, 417(1), 528-533. ##Alvarez-Mejia, L., Morales, J., Cruz, G. J., Olayo, M.-G., Olayo, R., Díaz-Ruíz, A., . . . Morales-Guadarrama, A. (2015). Functional recovery in spinal cord injured rats using polypyrrole/iodine implants and treadmill training. Journal of Materials Science: Materials in Medicine, 26, 1-11. ##Astorino, T. A., Harness, E. T., & Witzke, K. A. (2015). Chronic activity-based therapy does not improve body composition, insulin-like growth factor-I, adiponectin, or myostatin in persons with spinal cord injury. The journal of spinal cord medicine, 38(5), 615-625. ##Baligand, C., Gilson, H., Menard, J., Schakman, O., Wary, C., Thissen, J.-P., & Carlier, P. (2010). Functional assessment of skeletal muscle in intact mice lacking myostatin by concurrent NMR imaging and spectroscopy. Gene therapy, 17(3), 328-337. ##Basso, D., Beattie, M., Bresnahan, J., Anderson, D., Faden, A., Gruner, J., Nockels, R. (1996). MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Journal of Neurotrauma, 13(7), 343-359. ##Byrnes, K. R., Fricke, S. T., & Faden, A. I. (2010). Neuropathological differences between rats and mice after spinal cord injury. Journal of Magnetic Resonance Imaging, 32(4), 836-846. ##Chaplin, A., Carpéné, C., & Mercader, J. (2018). Resveratrol, metabolic syndrome, and gut microbiota. Nutrients, 10(11), 1651. ##Chien, Y.-H., Han, D.-S., Hwu, W.-L., Thurberg, B. L., & Yang, W.-S. (2013). Myostatin and insulin-like growth factor I: potential therapeutic biomarkers for pompe disease. PloS one, 8(8), e71900. ##Coyoy-Salgado, A., Segura-Uribe, J. J., Guerra-Araiza, C., Orozco-Suárez, S., Salgado-Ceballos, H., Feria-Romero, I. A., Orozco-Barrios, C. E. (2019). The importance of natural antioxidants in the treatment of spinal cord injury in animal models: an overview. Oxidative medicine and cellular longevity, 2019: 12;2019:3642491. ##Feng, Y., He, Z., Mao, C., Shui, X., & Cai, L. (2019). Therapeutic effects of resveratrol liposome on muscle injury in rats. Medical science monitor: international medical journal of experimental and clinical research, 2:25:2377-2385. ##Girbovan, C., Kent, P., Merali, Z., & Plamondon, H. (2016). Dose-related effects of chronic resveratrol administration on neurogenesis, angiogenesis, and corticosterone secretion are associated with improved spatial memory retention following global cerebral ischemia. Nutritional Neuroscience, 19(8), 352-368. ##Gómara-Toldrà, N., Sliwinski, M., & Dijkers, M. P. (2014). Physical therapy after spinal cord injury: a systematic review of treatments focused on participation. The journal of spinal cord medicine, 37(4), 371-379. ##Gorgey, A., & Dudley, G. (2007). Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord, 45(4), 304-309. ##Graham, Z. A., Collier, L., Peng, Y., Saéz, J. C., Bauman, W. A., Qin, W., & Cardozo, C. P. (2016). A soluble activin receptor IIB fails to prevent muscle atrophy in a mouse model of spinal cord injury. Journal of Neurotrauma, 33(12), 1128-1135. ##Han, D.-S., Hsiao, M.-Y., Wang, T.-G., Chen, S.-Y., & Yang, W.-S. (2016). Association of serum myokines and aerobic exercise training in patients with spinal cord injury: an observational study. BMC neurology, 16, 1-7. ##Han, D. S., Chen, Y. M., Lin, S. Y., Chang, H. H., Huang, T. M., Chi, Y. C., & Yang, W. S. (2011). Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clinical endocrinology, 75(6), 857-863. ##Hart, N., Sarga, L., Csende, Z., Koltai, E., Koch, L. G., Britton, S. L., Radak, Z. (2013). Resveratrol enhances exercise training responses in rats selectively bred for high running performance. Food and chemical toxicology, 61, 53-59. ##Harvey, L., Lin, C.-W., Glinsky, J., & De Wolf, A. (2009). The effectiveness of physical interventions for people with spinal cord injuries: a systematic review. Spinal Cord, 47(3), 184-195. ##Invernizzi, M., Carda, S., Rizzi, M., Grana, E., Squarzanti, D., Cisari, C., Renò, F. (2015). Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients. Spinal Cord, 53(8), 615-620. ##Jackson, J. R., Ryan, M. J., Hao, Y., & Alway, S. E. (2010). Mediation of endogenous antioxidant enzymes and apoptotic signaling by resveratrol following muscle disuse in the gastrocnemius muscles of young and old rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 299(6), 1572-1581. ##Jiang, Q., Cheng, X., Cui, Y., Xia, Q., Yan, X., Zhang, M., Huang, Y. (2019). Resveratrol regulates skeletal muscle fibers switching through the AdipoR1-AMPK-PGC-1α pathway. Food & Function, 10(6), 3334-3343. ##Krakoff, J., Funahashi, T., Stehouwer, C. D., Schalkwijk, C. G., Tanaka, S., Matsuzawa, Y., Knowler, W. C. (2003). Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes care, 26(6), 1745-1751. ##Krause, M. P., Liu, Y., Vu, V., Chan, L., Xu, A., Riddell, M. C., Hawke, T. J. (2008). Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function. American Journal of Physiology-Cell Physiology, 295(1), 203-212. ##Lee, S.-J. (2007). Quadrupling muscle mass in mice by targeting TGF-ß signaling pathways. PloS one, 2(8), e789. ##Mañas-García, L., Denhard, C., Mateu, J., Duran, X., Gea, J., & Barreiro, E. (2021). Beneficial Effects of Resveratrol in Mouse Gastrocnemius: A Hint to Muscle Phenotype and Proteolysis. Cells, 10(9), 2436. ##Mañas-García, L., Guitart, M., Duran, X., & Barreiro, E. (2020). Satellite cells and markers of muscle regeneration during unloading and reloading: Effects of treatment with resveratrol and curcumin. Nutrients, 12(6), 1870. ##Marimuthu, K., Murton, A. J., & Greenhaff, P. L. (2011). Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. Journal of applied physiology, 110(2), 555-560. ##Mohan, S., & Baylink, D. (2002). Beyond carrier proteins: IGF-binding proteins are multifunctional and act via IGF-dependent and–independent mechanisms. J endocrinol, 175, 19-31. ##Mohr, T., Andersen, J. L., Biering-Sørensen, F., Galbo, H., Bangsbo, J., Wagner, A., & Kjaer, M. (1997). Long term adaptation to electrically induced cycle training in severe spinal cord injured individuals. Spinal Cord, 35(1), 1-16. Momken, I., Stevens, L., Bergouignan, A., Desplanches, D., Rudwill, F., Chery, I., Sebedio, J. L. (2011). Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. The FASEB Journal, 25(10), 3646-3660##. Montesano, A., Luzi, L., Senesi, P., Mazzocchi, N., & Terruzzi, I. (2013). Resveratrol promotes myogenesis and hypertrophy in murine myoblasts. Journal of translational medicine, 11(1), 1-15. ##Mouisel, E., Relizani, K., Mille-Hamard, L., Denis, R., Hourdé, C., Agbulut, O., Vignaud, A. (2014). Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 307(4), R444-R454. ##Otzel, D. M., Lee, J., Ye, F., Borst, S. E., & Yarrow, J. F. (2018). Activity-based physical rehabilitation with adjuvant testosterone to promote neuromuscular recovery after spinal cord injury. International Journal of Molecular Sciences, 19(6), 1701. ##Paoli, A., Pacelli, Q. F., Neri, M., Toniolo, L., Cancellara, P., Canato, M., Faggian, D. (2015). Protein supplementation increases postexercise plasma myostatin concentration after 8 weeks of resistance training in young physically active subjects. Journal of medicinal food, 18(1), 137-143. ##Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J.-C., Sassi, A. H., Bonnieu, A. (2014). Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cellular and Molecular Life Sciences, 71(22), 4361-4371. ##Sahebkar, A., Serban, C., Ursoniu, S., Wong, N. D., Muntner, P., Graham, I. M., Sperling, L. S. (2015). Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors—Results from a systematic review and meta-analysis of randomized controlled trials. International journal of cardiology, 189, 47-55. ##Samarghandian, S., Pourbagher-Shahri, A. M., Ashrafizadeh, M., Khan, H., Forouzanfar, F., Aramjoo, H., & Farkhondeh, T. (2020). A pivotal role of the nrf2 signaling pathway in spinal cord injury: A prospective therapeutics study. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 19(3), 207-219. ##Sandrow-Feinberg, H. R., Izzi, J., Shumsky, J. S., Zhukareva, V., & Houle, J. D. (2009). Forced exercise as a rehabilitation strategy after unilateral cervical spinal cord contusion injury. Journal of Neurotrauma, 26(5), 721-731. ##Schiaffino, S., Reggiani, C., Akimoto, T., & Blaauw, B. (2021). Molecular mechanisms of skeletal muscle hypertrophy. Journal of neuromuscular diseases, 8(2), 169-183. ##Schoenfeld, A. J., Laughlin, M. D., McCriskin, B. J., Bader, J. O., Waterman, B. R., & Belmont Jr, P. J. (2013). Spinal injuries in United States military personnel deployed to Iraq and Afghanistan: an epidemiological investigation involving 7877 combat casualties from 2005 to 2009. Spine, 38(20), 1770-1778. ##Shyu, K.-G., Ko, W.-H., Yang, W.-S., Wang, B.-W., & Kuan, P. (2005). Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovascular research, 68(3), 405-414. ##Talmadge, R., Castro, M., Apple Jr, D., & Dudley, G. (2002). Phenotypic adaptations in human muscle fibers 6 and 24 wk after spinal cord injury. Journal of applied physiology, 92(1), 147-154. ##Xu, X., Talifu, Z., Zhang, C.-J., Gao, F., Ke, H., Pan, Y.-Z., Jing, Y.-L. (2023). Mechanism of skeletal muscle atrophy after spinal cord injury: A narrative review. Frontiers in Nutrition, 10. ##Ye, F., Baligand, C., Keener, J. E., Vohra, R., Lim, W., Ruhella, A., Thompson, F. (2013). Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization. Journal of Neurotrauma, 30(3), 227-235. ##Yin, L., Li, N., Jia, W., Wang, N., Liang, M., Yang, X., & Du, G. (2021). Skeletal muscle atrophy: From mechanisms to treatments. Pharmacological research, 172, 105807. ##
)